Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

09 juil. 2014 09h00 HE | Source: PharmaCyte Biotech, Inc.

Nuvilex Scheduled to Begin Preclinical Studies in Early August

SILVER SPRING, Md., July 9, 2014 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of...
01 juil. 2014 09h00 HE | Source: PharmaCyte Biotech, Inc.

Nuvilex Executives Attend 2014 BIO International Convention

SILVER SPRING, Md., July 1, 2014 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of...
30 mai 2014 09h00 HE | Source: PharmaCyte Biotech, Inc.

Nuvilex to Present at the LD MICRO Invitational Conference on June 4, 2014

SILVER SPRING, Md., May 30, 2014 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of...
29 mai 2014 10h01 HE | Source: PharmaCyte Biotech, Inc.

Nuvilex Enters Into an At the Market Banking Agreement With Chardan Capital Markets

SILVER SPRING, Md., May 29, 2014 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of...
28 mai 2014 14h00 HE | Source: PharmaCyte Biotech, Inc.

Nuvilex to Present at the Third Annual Marcum MicroCap Conference

SILVER SPRING, Md., May 28, 2014 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of...
21 mai 2014 09h00 HE | Source: PharmaCyte Biotech, Inc.

Nuvilex and Translational Drug Development (TD2) Begin Preparations for US-Based Studies on Symptoms Associated With Pancreatic Cancer

SILVER SPRING, Md., May 21, 2014 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of...
09 mai 2014 09h00 HE | Source: PharmaCyte Biotech, Inc.

Nuvilex Signs Agreement to Study Development of Cannabis-Based Cancer Treatments

SILVER SPRING, Md., May 9, 2014 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of...
01 mai 2014 09h00 HE | Source: PharmaCyte Biotech, Inc.

Nuvilex Adds World Renowned Oncologist and Gastroenterologist to Play Major Role in Late Phase Clinical Trial

SILVER SPRING, Md., May 1, 2014 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of...
28 avr. 2014 09h00 HE | Source: PharmaCyte Biotech, Inc.

Medical Marijuana Sciences' Scientific Advisory Board Chairman Dr. Mark L. Rabe Educates Professional Fiduciaries on the Benefits of Medical Marijuana

SILVER SPRING, Md., April 28, 2014 (GLOBE NEWSWIRE) -- Medical Marijuana Sciences, Inc. (MMS), a subsidiary of Nuvilex, Inc. (OTCQB:NVLX), a clinical stage international biotechnology company...
25 avr. 2014 09h00 HE | Source: PharmaCyte Biotech, Inc.

Medical Marijuana Sciences' Scientific Advisory Board Chairman Dr. Mark L. Rabe Presents to Pain Medicine and Other Physicians at the University of California San Diego

SILVER SPRING, Md., April 25, 2014 (GLOBE NEWSWIRE) -- Medical Marijuana Sciences, Inc. (MMS), a subsidiary of Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and...

Page précédente

Page suivante